Cancer treatment threatened by increasingly ineffective antimicrobial drugs

  17 May 2021

As pathogens become ever more resistant to antimicrobial drugs such as antibiotics, people living with cancer run a growing risk of adverse treatment outcomes, including death from an infection, even though their cancer is treatable.

Infections are one of the most common complications that a person living with cancer faces. As many as 1 in 5 cancer patients undergoing treatment are hospitalised due to infection, and antibiotics are the main line of defence.

A study on AMR in the US estimates that a 30% reduction in the efficiency of antibiotics used for cancer patients (in relation to surgery or chemotherapy) would cause an additional 120,000 infections and 6,300 deaths each year.  

Further reading: UICC
Author(s): UICC
Healthy Patients  


Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre


JSS University


Global Ambassador Network

Welcome at the AMR Insights Ambassador Network!

The AMR Insights Ambassador Network is a growing, distinctive group of professionals who stand out for their commitment, willingness to cooperate and open attitude to combat Antimicrobial resistance (AMR).

More information and free-of-charge registration
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!